CVS Health Corporation

NYSE:CVS Rapport sur les actions

Capitalisation boursière : US$73.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CVS Health Gestion

Gestion contrôle des critères 3/4

Le PDG CVS Health's est Karen Lynch, nommé en Feb2021, a un mandat de 3.5 ans. La rémunération annuelle totale est $ 21.62M, composée du salaire de 6.9% et des bonus 93.1%, y compris les actions et options de la société. détient directement 0.04% des actions de la société, d'une valeur de $ 29.53M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.4 ans et 6.5 ans.

Informations clés

Karen Lynch

Directeur général

US$21.6m

Rémunération totale

Pourcentage du salaire du PDG6.9%
Durée du mandat du directeur général3.5yrs
Propriété du PDG0.04%
Durée moyenne d'occupation des postes de direction2.4yrs
Durée moyenne du mandat des membres du conseil d'administration6.5yrs

Mises à jour récentes de la gestion

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

Recent updates

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

Analyse de la rémunération des PDG

Comment la rémunération de Karen Lynch a-t-elle évolué par rapport aux bénéfices de CVS Health?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

US$7b

Mar 31 2024n/an/a

US$7b

Dec 31 2023US$22mUS$2m

US$8b

Sep 30 2023n/an/a

US$9b

Jun 30 2023n/an/a

US$3b

Mar 31 2023n/an/a

US$4b

Dec 31 2022US$21mUS$1m

US$4b

Sep 30 2022n/an/a

US$3b

Jun 30 2022n/an/a

US$8b

Mar 31 2022n/an/a

US$8b

Dec 31 2021US$20mUS$1m

US$8b

Sep 30 2021n/an/a

US$8b

Jun 30 2021n/an/a

US$7b

Mar 31 2021n/an/a

US$7b

Dec 31 2020US$11mUS$1m

US$7b

Rémunération vs marché: La rémunération totale de Karen ($USD 21.62M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 13.21M ).

Rémunération et revenus: La rémunération de Karen a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Karen Lynch (61 yo)

3.5yrs

Titularisation

US$21,615,034

Compensation

Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Karen Lynch
President3.5yrsUS$21.62m0.040%
$ 29.7m
Thomas Cowhey
Executive VP & CFOless than a yearUS$4.58m0.0028%
$ 2.1m
Tilak Mandadi
Executive VP of Ventures and Chief Digital2.1yrsUS$8.88m0.0016%
$ 1.2m
Samrat Khichi
Executive VP1.5yrsUS$11.89m0.00078%
$ 576.5k
Prem Shah
Executive VP2.8yrsUS$8.58m0.0037%
$ 2.7m
Vijay Patel
Senior Director of Business Development & CVS Health and Partner & Co-Founderno datapas de donnéespas de données
James Clark
Senior VP5.8yrspas de données0.00067%
$ 495.2k
Laurence McGrath
Senior Vice President of Business Development & Investor Relations2.1yrspas de donnéespas de données
David Falkowski
Executive VP & Chief Compliance Officerno datapas de donnéespas de données
Laurie Havanec
Executive VP & Chief People Officer3.5yrspas de données0.0030%
$ 2.2m
J. Joyner
Executive Vice President & President of CVS Caremark1.6yrspas de données0.0032%
$ 2.4m
Michelle Peluso
Executive VP and Chief Customer & Experience Officer3.6yrspas de données0.0099%
$ 7.3m

2.4yrs

Durée moyenne de l'emploi

59yo

Âge moyen

Gestion expérimentée: L'équipe de direction de CVS est considérée comme expérimentée (ancienneté moyenne 2.4 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Karen Lynch
President3.5yrsUS$21.62m0.040%
$ 29.7m
J. Kirby
Independent Directorless than a yearUS$195.42k0.00045%
$ 332.6k
Roger Farah
Independent Chairman5.8yrsUS$576.50k0.00033%
$ 243.9k
Mary Schapiro
Independent Director7.3yrsUS$301.50k0.00094%
$ 694.7k
Nancy-Ann DeParle
Independent Director10.9yrsUS$321.50k0.0025%
$ 1.9m
Anne Finucane
Independent Director13.6yrsUS$321.50k0.0026%
$ 1.9m
C. Brown
Independent Director17.4yrsUS$321.50k0.0097%
$ 7.1m
Jean-Pierre Millon
Independent Director17.4yrsUS$321.50k0.0088%
$ 6.5m
Alecia DeCoudreaux
Independent Director9.4yrsUS$301.50k0.00024%
$ 177.4k
Fernando Aguirre
Independent Director5.8yrsUS$318.17k0.0028%
$ 2.1m
Jeffrey Balser
Independent Director1.9yrsUS$301.50k0.00058%
$ 428.7k
Michael Mahoney
Independent Directorless than a yearUS$167.50k0.0011%
$ 798.2k

6.5yrs

Durée moyenne de l'emploi

67.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de CVS sont considérés comme expérimentés (ancienneté moyenne 6.5 ans).